Clonidine controlled release - Concordia Pharmaceuticals
Alternative Names: CloniBID; Clonicel; clonidine HCl sustained release; Jenloga XR; KapvayLatest Information Update: 05 Nov 2023
At a glance
- Originator Addrenex Pharmaceuticals
- Developer Concordia Pharmaceuticals
- Class Analgesics; Anti-inflammatories; Antiglaucomas; Antimigraines; Behavioural disorder therapies; Centrally-acting antihypertensives; Chlorobenzenes; Imidazolines; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor agonists; Imidazoline receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Attention-deficit hyperactivity disorder
- Market Withdrawal Hypertension